Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112380326 | 11238032 | 6 | F | 201410 | 20160823 | 20150703 | 20160830 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-042380 | BRISTOL MYERS SQUIBB | 88.00 | YR | F | Y | 50.00000 | KG | 20160830 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112380326 | 11238032 | 1 | PS | APIXABAN | APIXABAN | 1 | Oral | 2.5 MG, BID | 1145 | MG | Y | 202155 | 2.5 | MG | BID | ||||
| 112380326 | 11238032 | 2 | SS | APIXABAN | APIXABAN | 1 | Oral | 2.5 MG, BID | 1145 | MG | Y | 202155 | 2.5 | MG | BID | ||||
| 112380326 | 11238032 | 3 | SS | APIXABAN | APIXABAN | 1 | Oral | 2.5 MG, UNK | 1145 | MG | Y | 202155 | 2.5 | MG | |||||
| 112380326 | 11238032 | 4 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | QD | |||||||
| 112380326 | 11238032 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 112380326 | 11238032 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 112380326 | 11238032 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, QD | 0 | 15 | MG | QD | |||||||
| 112380326 | 11238032 | 8 | C | LASIX | FUROSEMIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 112380326 | 11238032 | 9 | C | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | 2.5 MG, UNK | 0 | 2.5 | MG | TABLET | |||||||
| 112380326 | 11238032 | 10 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 112380326 | 11238032 | 11 | C | ATELEC | CILNIDIPINE | 1 | Unknown | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 112380326 | 11238032 | 12 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 112380326 | 11238032 | 13 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 112380326 | 11238032 | 14 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 30 MG, QD | 0 | 30 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112380326 | 11238032 | 1 | Cerebrovascular accident prophylaxis |
| 112380326 | 11238032 | 4 | Thrombosis prophylaxis |
| 112380326 | 11238032 | 5 | Hyperlipidaemia |
| 112380326 | 11238032 | 7 | Gastric ulcer |
| 112380326 | 11238032 | 8 | Renal disorder |
| 112380326 | 11238032 | 9 | Hypertension |
| 112380326 | 11238032 | 10 | Hypertension |
| 112380326 | 11238032 | 11 | Hypertension |
| 112380326 | 11238032 | 12 | Hyperlipidaemia |
| 112380326 | 11238032 | 13 | Renal disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112380326 | 11238032 | OT |
| 112380326 | 11238032 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112380326 | 11238032 | Angina unstable | |
| 112380326 | 11238032 | Arterial repair | |
| 112380326 | 11238032 | Arteriogram coronary | |
| 112380326 | 11238032 | Contraindicated product administered | |
| 112380326 | 11238032 | Transfusion | |
| 112380326 | 11238032 | Vascular pseudoaneurysm |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112380326 | 11238032 | 1 | 20140306 | 20141020 | 0 | |
| 112380326 | 11238032 | 2 | 20141021 | 20141023 | 0 | |
| 112380326 | 11238032 | 3 | 20141028 | 0 | ||
| 112380326 | 11238032 | 5 | 20160508 | 0 | ||
| 112380326 | 11238032 | 6 | 20150509 | 20150828 | 0 | |
| 112380326 | 11238032 | 8 | 20150703 | 0 | ||
| 112380326 | 11238032 | 10 | 20140412 | 0 | ||
| 112380326 | 11238032 | 11 | 20150412 | 0 | ||
| 112380326 | 11238032 | 12 | 20150829 | 20151024 | 0 | |
| 112380326 | 11238032 | 13 | 20150704 | 20160212 | 0 | |
| 112380326 | 11238032 | 14 | 20160213 | 0 |